Management of reduced fetal movements

Fetal and Maternal Medicine Review

Volumn 24, Issue 4, 2013, Pages 201-231

  Higgins, L E ^a   Johnstone, E D ^a   Heazell, A E P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMNION FLUID; AWARENESS; BODY SIZE; CARDIOTOCOGRAPH; CLINICAL EXAMINATION; DELIVERY; DOPPLER FLOWMETRY; FETAL BIOPHYSICAL PROFILE; FETAL WELL BEING; FETUS; FETUS ECHOGRAPHY; FETUS MOVEMENT; FETUS SIZE; HORMONE SYNTHESIS; HUMAN; INTRAUTERINE GROWTH RETARDATION; MOTHER FETUS RELATIONSHIP; OXYGENATION; PLACENTA FUNCTION; PLACENTAL SIZE; PREGNANCY OUTCOME; REDUCED FETAL MOVEMENT; REVIEW; STILLBIRTH; UMBILICAL ARTERY; DISEASE ASSOCIATION; FETAL SIZE; FETUS DISEASE; FUNCTIONAL ASSESSMENT; META ANALYSIS (TOPIC); NUTRIENT UPTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); UMBILICAL CORD;

EID: 84898411189     PISSN: 09655395     EISSN: 14695065     Source Type: Journal    
DOI: 10.1017/S096553951300017X     Document Type: Review

References (184)

1. Neldam S. Fetal movements as an indicator of fetal well-being. Dan Med Bull 1983; 30(4): 274-8. (Pubitemid 13042635)
2. Gettinger A, Roberts AB, Campbell S. Comparison between subjective and ultrasound assessments of fetal movement. Br Med J 1978; 2(6130): 88-90. (Pubitemid 8363050)
3. D'Elia A, Pighetti M, Moccia G, Santangelo N. Spontaneous motor activity in normal fetuses. Early Hum Dev 2001; 65(2): 139-47. (Pubitemid 32964699)
4. Hertogs K, Roberts AB, Cooper D, Griffin DR, Campbell S. Maternal perception of fetal motor activity. Br Med J 1979; 2(6199): 1183-5. (Pubitemid 10202040)
5. Lowery CL, RussellWA,Wilson JD,Walls RC,Murphy P. Time-quantified fetal movement detection with two-transducer data fusion. Am J Obstet Gynecol 1995; 172(6): 1756-61; discussion 61-4.
6. Neldam S. Fetal movements. A comparison between maternal assessment and registration by means of dynamic ultrasound. Dan Med Bull 1982; 29(4): 197-9. (Pubitemid 12027391)
7. Neldam S, Jessen P. Fetal movements registered by the pregnant woman correlated to retrospective estimations of fetal movements from cardiotocographic tracings. Am J Obstet Gynecol. 1980; 136(8): 1051-4. (Pubitemid 10112861)
8. SchmidtW, Cseh I,Hara K, Kubli F. Maternal perception of fetalmovements and real-time ultrasound findings. J Perinat Med 1984; 12(6): 313-8. (Pubitemid 15134937)
9. Valentin L, Marsal K, Lindstrom K. Recording of foetal movements: a comparison of three methods. J Med Eng Technol 1986; 10(5): 239-47. (Pubitemid 17460302)
10. Froen JF. A kick from within: fetal movement counting and the cancelled progress in antenatal care. J Perinat Med 2004; 32(1): 13-24. (Pubitemid 38292627)
11. Dutton PJ, Warrander LK, Roberts SA, Bernatavicius G, Byrd LM, Gaze D, et al. Predictors of poor perinatal outcome following maternal perception of reduced fetal movements: a prospective cohort study. PLoS One 2012; 7(7): e39784.
12. HeazellAE, SumathiGM, Bhatti NR.What investigation is appropriate following maternal perception of reduced fetal movements? J Obstet Gynaecol 2005; 25(7): 648-50. (Pubitemid 43160998)
13. Whitworth M, Fisher M, Heazell AEP. Reduced fetal movements. London: Royal College of Obstetricians and Gynaecologists; 2011.
14. Heazell AE, Green M, Wright C, Flenady V, Froen JF. Midwives' and obstetricians' knowledge and management of women presenting with decreased fetal movements. Acta Obstet Gynecol Scand 2008; 87(3): 331-9. (Pubitemid 351317480)
15. Natale R, Nasello-Paterson C, Turliuk R. Longitudinal measurements of fetal breathing, body movements, heart rate, and heart rate accelerations and decelerations at 24 to 32 weeks of gestation. Am J Obstet Gynecol 1985; 151(2): 256-63. (Pubitemid 15240269)
16. Pearson JF, Weaver JB. Fetal activity and fetal wellbeing: an evaluation. Br Med J 1976; 1(6021): 1305-7.
17. Tuffnell DJ, Cartmill RS, Lilford RJ. Fetal movements: factors affecting their perception. Eur J Obstet Gynecol Reprod Biol 1991; 39(3): 165-7.
18. Fisher M. Reduced fetal movements: a research-based project. Br J Midwifery 1999; 7(12): 733-7.
19. Hijazi ZR, East CE. Factors affecting maternal perception of fetal movement. Obstet Gynecol Surv 2009; 64(7): 489-97; quiz 99.
20. Mulder EJ, Derks JB, Visser GH. Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. Br J Obstet Gynaecol 1997; 104(11): 1239-47. (Pubitemid 27485490)
21. Jackson JR, Kleeman S, Doerzbacher M, LambersDS. The effect of glucocorticosteroid administration on fetal movements and biophysical profile scores in normal pregnancies. J Matern Fetal Neonatal Med 2003; 13(1): 50-3. (Pubitemid 36216535)
22. Mahendru A, Gajjar K, Bashir T. Idiopathic chronic fetomaternal haemorrhage presenting with reduced fetal movements. J Obstet Gynaecol 2007; 27(8): 848-9.
23. Wilcock FM, Kadir RA. Fetomaternal haemorrhage: a cause for unexplained neonatal death, presenting with reduced fetal movements and non-reactive fetal heart trace. J Obstet Gynaecol 2004; 24(4): 456-7. (Pubitemid 38824106)
24. Rayburn WF, Barr M. Activity patterns in malformed fetuses. Am J Obstet Gynecol 1982; 142(8): 1045-8. (Pubitemid 12150576)
25. Stoll C, Ehret-Mentre MC, Treisser A, Tranchant C. Prenatal diagnosis of congenital myasthenia with arthrogryposis in a myasthenic mother. Prenat Diagn 1991; 11(1): 17-22.
26. Hoffmann R, Lohner M, Bohm N, Leititis J, Helwig H. Restrictive dermopathy: a lethal congenital skin disorder. Eur J Pediatr 1993; 152(2): 95-8. (Pubitemid 23035724)
27. Hsu CD, Feng TI, Crawford TO, Johnson TR. Unusual fetal movement in congenital myotonic dystrophy. Fetal Diagn Ther 1993; 8(3): 200-2. (Pubitemid 23284455)
28. Chen H, Blackburn WR, Wertelecki W. Fetal akinesia and multiple perinatal fractures. Am J Med Genet 1995; 55(4): 472-7.
29. Heazell AE, Martindale EA. Can post-mortem examination of the placenta help determine the cause of stillbirth? J Obstet Gynaecol 2009; 29(3): 225-8.
30. Tantbirojn P, Saleemuddin A, Sirois K, Crum CP, Boyd TK, Tworoger S, et al. Gross abnormalities of the umbilical cord: related placental histology and clinical significance. Placenta 2009; 30(12): 1083-8.
31. Dugoff L, Cuckle HS, Hobbins JC, Malone FD, Belfort MA, Nyberg DA, et al. Prediction of patientspecific risk for fetal loss using maternal characteristics and first-and second-trimester maternal serum Down syndrome markers. Am J Obstet Gynecol 2008; 199(3): 290 e1-6.
32. Biswas S, Ghosh SK. Gross morphological changes of placentas associated with intrauterine growth restriction of fetuses: a case control study. Early Hum Dev 2008; 84(6): 357-62.
33. Sibley CP, Turner MA, Cetin I, Ayuk P, Boyd CA, D'Souza SW, et al. Placental phenotypes of intrauterine growth. Pediatr Res 2005; 58(5): 827-32. (Pubitemid 41511049)
34. Roje D, Tomas SZ, Prusac IK,Capkun V, Tadin I. Trophoblast apoptosis in human termplacentas from pregnancies complicated with idiopathic intrauterine growth retardation. J Matern Fetal Neonatal Med 2011; 24(5): 745-51.
35. Wallace JM, Horgan GW, Bhattacharya S. Placentalweight and efficiency in relation tomaternal body mass index and the risk of pregnancy complications in women delivering singleton babies. Placenta 2012; 33(8): 611-8.
36. Lao MR, Calhoun BC, Bracero LA, Wang Y, Seybold DJ, Broce M, et al. The ability of the quadruple test to predict adverse perinatal outcomes in a high-risk obstetric population. J Med Screen 2009; 16(2): 55-9.
37. Salas SP, Marshall G, Gutierrez BL, Rosso P. Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension 2006; 47(2): 203-8. (Pubitemid 43189764)
38. Mills TA,Wareing M, BuggGJ, Greenwood SL, Baker PN. Chorionic plate artery function andDoppler indices in normal pregnancy and intrauterine growth restriction. Eur J Clin Invest 2005; 35(12): 758-64. (Pubitemid 41783593)
39. Mills TA, Greenwood SL, Johnstone ED, Sibley CP, Wareing M. Mechanical and receptor mediated responses of placental chorionic plate arteries are altered in fetal growth restriction. Reprod Sci 2011; 19(3): F-291.
40. Warrander LK, Batra G, Bernatavicius G, Greenwood SL, Dutton P, Jones RL, et al. Maternal perception of reduced fetal movements is associated with altered placental structure and function. PLoS One 2012; 7(4): e34851.
41. Gardosi J, Kady SM, McGeown P, Francis A, Tonks A. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ 2005; 331(7525): 1113-7. (Pubitemid 41634895)
42. Korteweg FJ, Gordijn SJ, Timmer A, Holm JP, Ravise JM, Erwich JJ. A placental cause of intra-uterine fetal death depends on the perinatal mortality classification system used. Placenta 2008; 29(1): 71-80.
43. Andonotopo W, Kurjak A. The assessment of fetal behavior of growth restricted fetuses by 4D sonography. J Perinat Med 2006; 34(6): 471-8. (Pubitemid 44877390)
44. Saastad E, Winje BA, Stray Pedersen B, Froen JF. Fetal movement counting improved identification of fetal growth restriction and perinatal outcomes: a multi-centre, randomized, controlled trial. PLoS One 2011; 6(12): e28482.
45. Warrander LK, Heazell AE. Identifying placental dysfunction in women with reduced fetal movements can be used to predict patients at increased risk of pregnancy complications. Med Hypotheses 2011; 76(1): 17-20.
46. Heazell AE, Froen JF. Methods of fetal movement counting and the detection of fetal compromise. J Obstet Gynaecol 2008; 28(2): 147-54. (Pubitemid 351507670)
47. Efkarpidis S, Alexopoulos E, Kean L, Liu D, Fay T. Case-control study of factors associated with intrauterine fetal deaths. MedGenMed 2004; 6(2): 53.
48. Grant A, Elbourne D, Valentin L, Alexander S. Routine formal fetal movement counting and risk of antepartum late death in normally formed singletons. Lancet 1989; 2(8659): 345-9. (Pubitemid 19189064)
49. Leader LR, Baillie P, Van Schalkwyk DJ. Fetal movements and fetal outcome: a prospective study. Obstet Gynecol. 1981; 57(4): 431-6. (Pubitemid 11147050)
50. Pearson JF, Weaver JB. Fetal activity and fetal wellbeing: an evaluation. Br Med J 1976; 1(6021): 1305-7.
51. Sadovsky E, Ohel G, Havazeleth H, Steinwell A, Penchas S. The definition and the significance of decreased fetal movements. Acta Obstet Gynecol Scand 1983; 62(5): 409-13. (Pubitemid 14213526)
52. Moore TR, Piacquadio K. A prospective evaluation of fetal movement screening to reduce the incidence of antepartum fetal death. Am J Obstet Gynecol 1989; 160(5 Pt 1): 1075-80. (Pubitemid 19144462)
53. Valentin L, Marsal K,Wahlgren L. Subjective recording of fetal movements. III. Screening of a pregnant population; the clinical significance of decreased fetalmovement counts. Acta Obstet Gynecol Scand 1986; 65(7): 753-8. (Pubitemid 17200789)
54. CEMACH. Perinatal mortality 2007. London: CEMACH; 2009.
55. Maulik D (ed.). Doppler ultrasound in obstetrics and gynaecology. New York: Springer; 1997.
56. Mangesi L, Hofmeyr GJ. Fetal movement counting for assessment of fetal wellbeing. Cochrane Database Syst Rev. 2007; (1): CD004909.
57. Lobb MO, Beazley JM, Haddad NG. A controlled study of daily fetal movement counts in the prevention of stillbirths. J Obstet Gynaecol 1985; 6(2): 87-91. (Pubitemid 16197466)
58. Westgate J, Jamieson M. Stillbirths and fetal movements.NZ Med J 1986; 99(796): 114-6. (Pubitemid 16108416)
59. Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect". J Clin Epidemiol 2001; 54(3): 217-24. (Pubitemid 32162034)
60. Promoting awareness fetal movements to reduce fetal mortality stillbirth, a stepped wedge cluster randomised trial. (AFFIRM). http://www.clinicaltrials. gov/ct2/show/NCT01777022. Accessed on 16 October 2013.
61. National Collaborating Centre for Women's and Children's Health. Antenatal care: routine care for the healthy pregnant woman. London: National Institute for Health and Clinical Excellence; 2008; Contract No. CG62.
62. Grivell RM, Alfirevic Z, Gyte GM, Devane D. Antenatal cardiotocography for fetal assessment. Cochrane Database Syst Rev 2010; (1): CD007863.
63. Daly N, Brennan D, Foley M, O'Herlihy C. Cardiotocography as a predictor of fetal outcome in women presenting with reduced fetal movement. Eur J Obstet Gynecol Reprod Biol 2011; 159(1): 57-61.
64. Tan KH, Smyth R. Fetal vibroacoustic stimulation for facilitation of tests of fetalwellbeing. Cochrane Database Syst Rev 2001; (1): CD002963.
65. Tan KH, Sabapathy A. Fetal manipulation for facilitating tests of fetal wellbeing. Cochrane Database Syst Rev 2001; (4): CD003396.
66. Neilson JP. Fetal electrocardiogram (ECG) for fetal monitoring during labour. Cochrane Database Syst Rev 2006; 3: CD000116.
67. de Jong CL, Gardosi J, Dekker GA, Colenbrander GJ, van Geijn HP. Application of a customised birthweight standard in the assessment of perinatal outcome in a high risk population. Br J Obstet Gynaecol 1998; 105(5): 531-5. (Pubitemid 28261384)
68. Carberry AE, Gordon A, Bond DM, Hyett J, Raynes-Greenow CH, Jeffery HE. Customised versus population-based growth charts as a screening tool for detecting small for gestational age infants in low-risk pregnant women. Cochrane Database Syst Rev 2011; (12): CD008549.
69. Gardosi J, Francis A. Controlled trial of fundal height measurement plotted on customised antenatal growth charts. Br J Obstet Gynaecol 1999; 106(4): 309-17. (Pubitemid 29150253)
70. Owen P, Maharaj S, Khan KS, Howie PW. Interval between fetal measurements in predicting growth restriction. Obstet Gynecol 2001; 97(4): 499-504.
71. Gardosi J, Francis A. Controlled trial of fundal height measurement plotted on customised antenatal growth charts. Br J Obstet Gynaecol 1999; 106(4): 309-17. (Pubitemid 29150253)
72. Neilson J. Symphysis-fundal height measurement in pregnancy. Cochrane Database Syst Rev. 1998; (1): CD000944.
73. Morse K, Williams A, Gardosi J. Fetal growth screening by fundal height measurement. Best Pract Res Clin Obstet Gynaecol 2009; 23(6): 809-18.
74. Robson SC, Martin WL, Morris RK. The investigation and management of the small-for-gestationalage fetus, 2nd edn. Longon: Royal College of Obstetricians and Gynaecologists; 2013.
75. Campbell S, Wilkin D. Ultrasonic measurement of fetal abdomen circumference in the estimation of fetal weight. Br J Obstet Gynaecol 1975; 82(9): 689-97.
76. Harding K, Evans S, Newnham J. Screening for the small fetus: a study of the relative efficacies of ultrasound biometry and symphysiofundal height. Aust N Z J Obstet Gynaecol 1995; 35(2): 160-4.
77. Hargreaves K, Cameron M, Edwards H, Gray R, Deane K. Is the use of symphysis-fundal height measurement and ultrasound examination effective in detecting small or large fetuses? J Obstet Gynaecol 2011; 31(5): 380-3.
78. Dudley NJ. A systematic review of the ultrasound estimation of fetal weight. Ultrasound Obstet Gynecol 2005; 25(1): 80-9. (Pubitemid 40128908)
79. Melamed N, Yogev Y, Meizner I, Mashiach R, Bardin R, Ben-Haroush A. Sonographic fetal weight estimation: which model should be used? J Ultrasound Med 2009; 28(5): 617-29.
80. Burd I, Srinivas S, Pare E, Dharan V, Wang E. Is sonographic assessment of fetal weight influenced by formula selection? J Ultrasound Med 2009; 28(8): 1019-24.
81. Kurmanavicius J, Burkhardt T,Wisser J, Huch R. Ultrasonographic fetal weight estimation: accuracy of formulas and accuracy of examiners by birth weight from 500 to 5000 g. J Perinat Med 2004; 32(2): 155-61. (Pubitemid 39220537)
82. Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements: a prospective study. Am J Obstet Gynecol 1985; 151(3): 333-7. (Pubitemid 15237550)
83. Schild RL, Maringa M, Siemer J, Meurer B, Hart N, Goecke TW, et al. Weight estimation by three-dimensional ultrasound imaging in the small fetus. Ultrasound Obstet Gynecol 2008; 32(2): 168-75.
84. Nabhan AF,Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. Cochrane Database Syst Rev 2008; (3): CD006593.
85. Bardakci M, Balci O, Acar A, ColakogluMC. Comparison of modified biophysical profile and doppler ultrasound in predicting the perinatal outcome at or over 36 weeks of gestation. Gynecol Obstet Invest 2010; 69(4): 245-50.
86. Baschat AA, Gembruch U, Harman CR. The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound Obstet Gynecol 2001; 18(6): 571-7. (Pubitemid 34063052)
87. Madazli R, Sen C, Uludag S, Ocak V. Doppler dynamics: their clinical significance and relationship with fetal blood gases and pH measurements. J Obstet Gynaecol 2001; 21(5): 448-52. (Pubitemid 32928216)
88. Chang TC, Robson SC, Spencer JA, Gallivan S. Prediction of perinatal morbidity at term in small fetuses: comparison of fetal growth and Doppler ultrasound. Br J Obstet Gynaecol 1994; 101(5): 422-7. (Pubitemid 24194474)
89. Oros D, Figueras F, Cruz-Martinez R, Meler E, Munmany M, Gratacos E. Longitudinal changes in uterine, umbilical and fetal cerebral Doppler indices in late-onset small-for-gestational age fetuses. Ultrasound Obstet Gynecol 2011; 37(2): 191-5.
90. Alfirevic Z, Stampalija T, Gyte GM. Fetal and umbilical Doppler ultrasound in high-risk pregnancies. Cochrane Database Syst Rev 2010; (1): CD007529.
91. Alfirevic Z, Stampalija T, Gyte GM. Fetal and umbilical Doppler ultrasound in normal pregnancy. Cochrane Database Syst Rev 2010; (8): CD001450.
92. Korszun P, Dubiel M, Kudla M, Gudmundsson S. Doppler velocimetry for predicting outcome of pregnancies with decreased fetal movements. Acta Obstet Gynecol Scand. 2002; 81(10): 926-30. (Pubitemid 35176984)
93. Dubiel M, Gudmundsson S, Thuring-Jonsson A, Maesel A, Marsal K. Doppler velocimetry and nonstress test for predicting outcome of pregnancies with decreased fetalmovements. Am J Perinatol 1997; 14(3): 139-44. (Pubitemid 27143339)
94. Vintzileos AM, Bors-Koefoed R, Pelegano JF, CampbellWA, Rodis JF, Nochimson DJ, et al. The use of fetal biophysical profile improves pregnancy outcome in premature rupture of the membranes. Am J Obstet Gynecol 1987; 157(2): 236-40.
95. Lalor JG, Fawole B, Alfirevic Z, Devane D. Biophysical profile for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev 2008; (1): CD000038.
96. Baschat AA, Gembruch U, Harman CR. The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound Obstet Gynecol 2001; 18(6): 571-7. (Pubitemid 34063052)
97. O'Sullivan O, Stephen G, Martindale E, Heazell AE. Predicting poor perinatal outcome in women who present with decreased fetal movements. J Obstet Gynaecol. 2009; 29(8): 705-10.
98. SinhaD, Sharma A,Nallaswamy V, JayagopalN, Bhatti N. Obstetric outcome in women complaining of reduced fetal movements. J Obstet Gynaecol. 2007; 27(1): 41-3.
99. Heazell AE, Bernatavicius G, Roberts SA, Garrod A, Whitworth MK, Johnstone ED, et al. A randomised controlled trial comparing standard or intensive management of reduced fetalmovements after 36 weeks gestation: a feasibility study. BMC Pregnancy Childbirth 2013; 13: 95.
100. Froen JF, Arnestad M, Frey K, Vege A, Saugstad OD, Stray-Pedersen B. Risk factors for sudden intrauterine unexplained death: epidemiologic characteristics of singleton cases in Oslo, Norway, 1986-1995. Am J Obstet Gynecol 2001; 184(4): 694-702. (Pubitemid 32234986)
101. Gulmezoglu AM, Crowther CA, Middleton P. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database Syst Rev 2006; (4): CD004945.
102. Winje BA, Roald B, Kristensen NP, Froen JF. Placental pathology in pregnancies with maternally perceived decreased fetal movement: a population-based nested case-cohort study. PLoS One 2012; 7(6): e39259.
103. Rizzo G, Capponi A, Cavicchioni O, Vendola M, Arduini D. First trimester uterine Doppler and three-dimensional ultrasound placental volume calculation in predicting pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2008; 138(2): 147-51. (Pubitemid 351726049)
104. Thame M, Osmond C, Wilks R, Bennett FI, Forrester TE. Second-trimester placental volume and infant size at birth. Obstet Gynecol 2001; 98(2): 279-83. (Pubitemid 32744762)
105. Hafner E, Philipp T, Schuchter K, Dillinger-Paller B, Philipp K, Bauer P. Second-trimester measurements of placental volume by three-dimensional ultrasound to predict small-for-gestationalage infants. Ultrasound Obstet Gynecol 1998; 12(2): 97-102. (Pubitemid 28432877)
106. Toal M, Chan C, Fallah S, Alkazaleh F, Chaddha V, Windrim RC, et al. Usefulness of a placental profile in high-risk pregnancies. Am J Obstet Gynecol 2007; 196(4): 363 e1-7.
107. Toal M, Keating S, Machin G, Dodd J, Adamson SL, Windrim RC, et al. Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images. Am J Obstet Gynecol 2008; 198(3): 330 e1-7.
108. Toal M, Chaddha V,Windrim R, Kingdom J. Ultrasound detection of placental insufficiency inwomen with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin. J Obstet Gynaecol Can 2008; 30(3): 198-206.
109. McGinty P, Farah N, Dwyer VO, Hogan J, Reilly A, Turner MJ, et al. Ultrasound assessment of placental function: the effectiveness of placental biometry in a low-risk population as a predictor of a small for gestational age neonate. Prenat Diagn 2012; 32: 620-6.
110. Proctor LK, Toal M, Keating S, Chitayat D, Okun N, Windrim RC, et al. Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancyassociated plasma protein-A. Ultrasound Obstet Gynecol 2009; 34(3): 274-82.
111. Salafia CM, Yampolsky M, Shlakhter A, Mandel DH, Schwartz N. Variety in placental shape: when does it originate? Placenta 2012; 33(3): 164-70.
112. Yampolsky M, Salafia CM, Shlakhter O, Haas D, Eucker B, Thorp J. Centrality of the umbilical cord insertion in a human placenta influences the placental efficiency. Placenta 2009; 30(12): 1058-64.
113. Proctor LK, Fitzgerald B, Whittle WL, Mokhtari N, Lee E, Machin G, et al. Umbilical cord diameter percentile curves and their correlation to birth weight and placental pathology. Placenta 2013; 34(1): 62-6.
114. Hua M, Odibo AO, Macones GA, Roehl KA, Crane JP, Cahill AG. Single umbilical artery and its associated findings. Obstet Gynecol 2010; 115(5): 930-4.
115. Burshtein S, Levy A, Holcberg G, Zlotnik A, Sheiner E. Is single umbilical artery an independent risk factor for perinatal mortality? Arch Gynecol Obstet 2011; 283(2): 191-4.
116. Hill LM,Wibner D, Gonzales P, Chenevey P. Validity of transabdominal sonography in the detection of a two-vessel umbilical cord. Obstet Gynecol 2001; 98(5 Pt 1): 837-42. (Pubitemid 33042554)
117. Kirwan D and the Fetal Anomlay Screening Programme (NHS FASP). NHS Fetal Anomaly Screening Programme. 18+0-20+6 Weeks Fetal Anomaly Screening Scan National Standards and Guidance for England. http://fetalanomaly.screening.nhs. uk/getdata.php?id=11218. Accessed on 17 October 2013.
118. Patil NS, Kulkarni SR, Lohitashwa R. Umbilical cord coiling index and perinatal outcome. J Clin Diagn Res 2013; 7(8): 1675-7.
119. Ernst LM, Minturn L,Huang MH,Curry E, Su EJ.Gross patterns of umbilical cord coiling: correlations with placental histology and stillbirth. Placenta 2013; 34(7): 583-8.
120. Chitra T, Sushanth YS, Raghavan S. Umbilical coiling index as a marker of perinatal outcome: an analytical study. Obstet Gynecol Int 2012; (2012): 213689.
121. Pathak S, Sebire NJ, Hook L, Hackett G, Murdoch E, Jessop F, et al. Relationship between placental morphology and histological findings in an unselected population near term. Virchows Arch 2011; 459(1): 11-20.
122. Khong TY. Evidence-based pathology: umbilical cord coiling. Pathology 2010; 42(7): 618-22.
123. Peres LC, Taylor D. Overestimation of umbilical cord coiling index with segmental versus total length assessment. Pediatr Dev Pathol 2012; 15(4): 303-5.
124. Grannum PA, Berkowitz RL, Hobbins JC. The ultrasonic changes in the maturing placenta and their relation to fetal pulmonic maturity. Am J Obstet Gynecol 1979; 133(8): 915-22. (Pubitemid 9141397)
125. Viero S, Chaddha V, Alkazaleh F, Simchen MJ, Malik A, Kelly E, et al. Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries. Placenta 2004; 25(8-9): 735-41. (Pubitemid 39185951)
126. Proctor LK, WhittleWL, Keating S, Viero S, Kingdom JC. Pathologic basis of echogenic cystic lesions in the human placenta: role of ultrasound-guided wire localization. Placenta 2010; 31(12): 1111-5.
127. Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 2003; 189(4): 1173-7. (Pubitemid 37373917)
128. Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 2005; 106(2): 260-7. (Pubitemid 41023261)
129. Pergament E, Stein AK, Fiddler M, Cho NH, Kupferminc MJ. Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers. Obstet Gynecol 1995; 86(2): 255-8.
130. Dungan JS, Shulman LP, Phillips OP, Simpson JL, Meyer NL, Grevengood C, et al. Positive serum screening for fetal Down syndrome does not predict adverse pregnancy outcome in absence of fetal aneuploidy. J Soc Gynecol Investig 1994; 1(1): 55-8. (Pubitemid 2064211)
131. Letchworth AT, Slattery M, Dennis KJ. Clinical application of human-placental-lactogen values in late pregnancy. Lancet 1978; 1(8071): 955-7. (Pubitemid 8337715)
132. Isouard G. Value of total serum oestriol and human placental lactogen in the assessment of fetalplacental function. Aust N Z J Obstet Gynaecol 1979; 19(2): 69-76. (Pubitemid 10241044)
133. Zlatnik FJ, Varner MW, Hauser KS. Human placental lactogen: a predictor of perinatal outcome? Obstet Gynecol 1979; 54(2): 205-10. (Pubitemid 9206153)
134. Morrison I, Green P, Oomen B. The role of human placental lactogen assays in antepartum fetal assessment. Am J Obstet Gynecol 1980; 136(8): 1055-60. (Pubitemid 10112862)
135. Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes 2011; 18(6): 409-16.
136. Sorensen S, von Tabouillot D, Schioler V, Greisen G, Petersen S, Larsen T. Serial measurements of serum human placental lactogen (hPL) and serial ultrasound examinations in the evaluation of fetal growth. Early Hum Dev 2000; 60(1): 25-34.
137. Murao F. Measurements of the fetal liver size, hormonal level and pregnancy outcome. Gynecol Obstet Invest 1991; 32(3): 153-6.
138. Heazell AE, Bernatavicius G,Warrander L, BrownMC, Dunn WB. A metabolomic approach identifies differences in maternal serum in third trimester pregnancies that end in poor perinatal outcome. Reprod Sci 2012; 19(8): 863-75.
139. Chapell LC, Duckworth S, Griffin M, Tarft H, Seed P, Redman CW, et al. Plasma placental growth factor (PLGF) measurement in women presenting with suspected pre-eclampsia: the pelican study. Pregnancy Hypertens. 2012; 2(3): 233-4.
140. Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn 2008; 28(12): 1110-5.
141. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2008; 32(6): 732-9.
142. Benton SJ, Hu Y, Xie F, Kupfer K, Lee SW, Magee LA, et al. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Am J Obstet Gynecol 2012; 206(2): 163 e1-7.
143. Giles WB, Trudinger BJ, Baird PJ. Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation. Br J Obstet Gynaecol 1985; 92(1): 31-8. (Pubitemid 15195844)
144. Trudinger BJ, Giles WB, Cook CM, Bombardieri J, Collins L. Fetal umbilical artery flow velocity waveforms and placental resistance: clinical significance. Br J Obstet Gynaecol 1985; 92(1): 23-30. (Pubitemid 15195843)
145. TuuliMG, Odibo AO. First-and second-trimester screening for preeclampsia and intrauterine growth restriction. Clin Lab Med 2010; 30(3): 727-46.
146. Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 2008; 178(6): 701-11. (Pubitemid 351441471)
147. Li H, Gudnason H, Olofsson P, Dubiel M, Gudmundsson S. Increased uterine artery vascular impedance is related to adverse outcome of pregnancy but is present in only one-third of late third-trimester pre-eclamptic women. Ultrasound Obstet Gynecol 2005; 25(5): 459-63. (Pubitemid 40686040)
148. Meler E, Figueras F, BennasarM, Gomez O, Crispi F, Gratacos E. The prognostic role of uterine artery Doppler investigation in patients with severe early-onset preeclampsia. Am J Obstet Gynecol 2010; 202(6): 559 e1-4.
149. The GRIT Study Group. When do obstetricians recommend delivery for a high-risk preterm growthretarded fetus? The GRIT Study Group. Growth Restriction Intervention Trial. Eur J Obstet Gynecol Reprod Biol 1996; 67(2): 121-6.
150. Prior T, Mullins E, Bennett P, Kumar S. Prediction of intrapartum fetal compromise using the cerebroumbilical ratio: a prospective observational study. Am J Obstet Gynecol 2013; 208(2): 124 e1-6.
151. Hershkovitz R, Kingdom JC, Geary M, Rodeck CH. Fetal cerebral blood flow redistribution in late gestation: identification of compromise in small fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol 2000; 15(3): 209-12. (Pubitemid 33111838)
152. Tchirikov M, Rybakowski C, Huneke B, Schoder V, Schroder HJ. Umbilical vein blood volume flow rate and umbilical artery pulsatility as "venous-arterial index" in the prediction of neonatal compromise. Ultrasound Obstet Gynecol 2002; 20(6): 580-5. (Pubitemid 36002617)
153. Baschat AA, Gembruch U, Reiss I, Gortner L,Weiner CP, Harman CR. Relationship between arterial and venous Doppler and perinatal outcome in fetal growth restriction. Ultrasound Obstet Gynecol 2000; 16(5): 407-13. (Pubitemid 32158116)
154. Gudmundsson S, Korszun P, Olofsson P, Dubiel M. New score indicating placental vascular resistance. Acta Obstet Gynecol Scand 2003; 82(9): 807-12. (Pubitemid 37082909)
155. Bellotti M, Pennati G, De Gasperi C, Bozzo M, Battaglia FC, Ferrazzi E. Simultaneous measurements of umbilical venous, fetal hepatic, and ductus venosus blood flow in growth-restricted human fetuses. Am J Obstet Gynecol 2004; 190(5): 1347-58. (Pubitemid 38692220)
156. Hsieh FJ, Kuo PL, Ko TM, Chang FM, Chen HY. Doppler velocimetry of intraplacental fetal arteries. Obstet Gynecol 1991; 77(3): 478-82.
157. Mu J, Kanzaki T, Tomimatsu T, Fukuda H, Fujii E, Takeuchi H, et al. Investigation of intraplacental villous arteries by Doppler flow imaging in growth-restricted fetuses. Am J Obstet Gynecol 2002; 186(2): 297-302. (Pubitemid 34165451)
158. Lacin S,Demir N, Koyuncu F,Goktay Y. Value of intraplacental villous artery Doppler measurements in severe preeclampsia. J Postgrad Med 1996; 42(4): 101-4. (Pubitemid 126729345)
159. Jaffe R. Multigate spectral Doppler velocimetry for fast assessment of intraplacental fetal circulation: a preliminary study. J Ultrasound Med 1996; 15(4): 309-12. (Pubitemid 26107290)
160. Yagel S, Anteby EY, Shen O, Cohen SM, Friedman Z, Achiron R. Simultaneous multigate spectral Doppler imaging of the umbilical artery and placental vessels: novel ultrasound technology. Ultrasound Obstet Gynecol 1999; 14(4): 256-61.
161. Kirkinen P, Kurmanavichius J, Huch A, Huch R. Blood flow velocities in human intraplacental arteries. Acta Obstet Gynecol Scand 1994; 73(3): 220-4. (Pubitemid 24074439)
162. Rotmensch S, Liberati M, Luo JS, Kliman HJ, Gollin Y, Bellati U, et al. Color Doppler flow patterns and flow velocity waveforms of the intraplacental fetal circulation in growth-retarded fetuses. Am J Obstet Gynecol 1994; 171(5): 1257-64. (Pubitemid 24365725)
163. Jaffe R, Woods JR. Doppler velocimetry of intraplacental fetal vessels in the second trimester: improving the prediction of pregnancy complications in high-risk patients. Ultrasound Obstet Gynecol 1996; 8(4): 262-6. (Pubitemid 126720530)
164. Haberman S, Bracero LA, Byrne DW. Spectral Doppler index mapping of the umbilicoplacental circulation and pregnancy outcome. Gynecol Obstet Invest 2004; 58(1): 1-7. (Pubitemid 39140399)
165. Rizzo G, Silvestri E, Capponi A, Servadei F, Pietrolucci ME, Capece A, et al. Histomorphometric characteristics of first trimester chorionic villi in pregnancies with low serum pregnancyassociated plasma protein-A levels: relationship with placental three-dimensional power doppler ultrasonographic vascularization. J Matern Fetal Neonatal Med 2011; 24(2): 253-7.
166. Odeh M, Ophir E, Maximovsky O, Grinin V, Bornstein J. Placental volume and three-dimensional power Doppler analysis in prediction of pre-eclampsia and small for gestational age between Week 11 and 13 weeks and 6 days of gestation. Prenat Diagn 2011; 31(4): 367-71.
167. Odibo AO, Goetzinger KR, Huster KM, Christiansen JK, Odibo L, Tuuli MG. Placental volume and vascular flow assessed by 3D power Doppler and adverse pregnancy outcomes. Placenta 2011; 32(3): 230-4.
168. Hafner E, Metzenbauer M, Stumpflen I, Waldhor T, Philipp K. First trimester placental and myometrial blood perfusion measured by 3D power Doppler in normal and unfavourable outcome pregnancies. Placenta 2010; 31(9): 756-63.
169. Rizzo G, Capponi A, Pietrolucci ME, Capece A, Arduini D. First-trimester placental volume and vascularization measured by 3-dimensional power Doppler sonography in pregnancies with low serum pregnancy-associated plasma protein a levels. J Ultrasound Med 2009; 28(12): 1615-22.
170. Bozkurt N, Basgul Yigiter A, Gokaslan H, Kavak ZN. Correlations of fetal-maternal outcomes and first trimester 3-D placental volume/3-D power Doppler calculations. Clin ExpObstet Gynecol 2010; 37(1): 26-8.
171. Pomorski M, Zimmer M, Florjanski J, Michniewicz J, Wiatrowski A, Fuchs T, et al. Comparative analysis of placental vasculature and placental volume in normal and IUGR pregnancies with the use of three-dimensional power Doppler. Arch Gynecol Obstet 2012; 285(2): 331-7.
172. Raine-Fenning NJ, Nordin NM, Ramnarine KV, Campbell BK, Clewes JS, Perkins A, et al. Evaluation of the effect of machine settings on quantitative three-dimensional power Doppler angiography: an in-vitro flow phantom experiment. Ultrasound Obstet Gynecol 2008; 32(4): 551-9.
173. Raine-Fenning NJ, Nordin NM, Ramnarine KV, Campbell BK, Clewes JS, Perkins A, et al. Determining the relationship between three-dimensional power Doppler data and true blood flow characteristics: an in-vitro flow phantom experiment. Ultrasound Obstet Gynecol 2008; 32(4): 540-50.
174. Kudla MJ, Alcazar JL. Spatiotemporal image correlation with spherical sampling and high-definition flow: new 4-dimensional method for assessment of tissue vascularization changes during the cardiac cycle-reproducibility analysis. J Ultrasound Med 2012; 31(1): 73-80.
175. Welsh AW, Hou M, Meriki N, Martins WP. Spatiotemporal image correlation-derived volumetric Doppler impedance indices from spherical samples of the placenta: intraobserver reliability and correlation with conventional umbilical artery Doppler indices. Ultrasound Obstet Gynecol 2012; 40(4): 431-6.
176. Denison FC, Semple SI, Stock SJ, Walker J, Marshall I, Norman JE. Novel use of proton magnetic resonance spectroscopy (1HMRS) to non-invasively assess placental metabolism. PLoS One 2012; 7(8): e42926.
177. Alves TC, Jarak I, Carvalho RA. NMR methodologies for studying mitochondrial bioenergetics. Methods Mol Biol 2012; 810: 281-309.
178. Hibbeln JF, Shors SM, Byrd SE. MRI: is there a role in obstetrics? Clin Obstet Gynecol 2012; 55(1): 352-66.
179. Abramowicz JS, Sheiner E. In utero imaging of the placenta: importance for diseases of pregnancy. Placenta 2007; 28(Suppl. A): S14-22. (Pubitemid 46506064)
180. Andres RL, Saade G, Gilstrap LC,Wilkins I,Witlin A, Zlatnik F, et al. Association between umbilical blood gas parameters and neonatal morbidity and death in neonates with pathologic fetal acidemia. Am J Obstet Gynecol 1999; 181(4): 867-71. (Pubitemid 29503606)
181. Kakogawa J, Sumimoto K, Ho E, Kanayama N. Transabdominal measurement of oxygenation of the placenta by near-infrared spectroscopy. Semin Thromb Hemost 2005; 31(3): 297-301. (Pubitemid 40962390)
182. Kawamura T, Kakogawa J, Takeuchi Y, Takani S, Kimura S, Nishiguchi T, et al. Measurement of placental oxygenation by transabdominal near-infrared spectroscopy. Am J Perinatol 2007; 24(3): 161-6. (Pubitemid 46543417)
183. Kakogawa J, Sumimoto K, Kawamura T, Minoura S, Kanayama N. Noninvasive monitoring of placental oxygenation by near-infrared spectroscopy. Am J Perinatol 2010; 27(6): 463-8.
184. Huen I, Morris DM, Wright C, Parker GJ, Sibley CP, Johnstone ED, et al. R(1) and R(2)changes in the human placenta in response to maternal oxygen challenge. Magn Reson Med 2013; 70(5): 1427-33.